Your browser doesn't support javascript.
loading
Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel.
Terao, Toshiki; Kitamura, Wataru; Fujii, Nobuharu; Asada, Noboru; Kamoi, Chihiro; Fujiwara, Kanako; Kondo, Kaho; Matsubara, Chisato; Hayashino, Kenta; Seike, Keisuke; Fujiwara, Hideaki; Ennishi, Daisuke; Nishimori, Hisakazu; Fujii, Keiko; Matsuoka, Ken-Ichi; Maeda, Yoshinobu.
Afiliação
  • Terao T; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Kitamura W; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Fujii N; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan; Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan. Electronic address: nfujii@md.okayama-u.ac.jp.
  • Asada N; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Kamoi C; Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan.
  • Fujiwara K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Kondo K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Matsubara C; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Hayashino K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Seike K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Fujiwara H; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Ennishi D; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Nishimori H; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Fujii K; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan; Division of Clinical Laboratory, Okayama University Hospital, Okayama, Japan.
  • Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Maeda Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Transplant Cell Ther ; 29(9): 573.e1-573.e8, 2023 09.
Article em En | MEDLINE | ID: mdl-37394114
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão